Results: 2

1.
Figure 1

Figure 1. From: Similar and Promising Outcomes in Lymphoma Patients Treated with Myeloablative or Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation.

Unadjusted Kaplan-Meier estimates of overall survival (A) and progression-free survival (B) comparing myeloablative and NMA conditioning.

Marcie Tomblyn, et al. Biol Blood Marrow Transplant. ;14(5):538-545.
2.
Figure 2

Figure 2. From: Similar and Promising Outcomes in Lymphoma Patients Treated with Myeloablative or Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation.

Unadjusted Kaplan-Meier estimates for progression-free survival after NMA conditioning by histologic cohorts. Follicular/small lymphocytic lymphoma (SLL) (n = 24), Hodgkins (n = 23), other NHL (n = 29).

Marcie Tomblyn, et al. Biol Blood Marrow Transplant. ;14(5):538-545.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk